The Central Drugs Standard Control Organisation (CDSCO) has initiated a probe in connection with the death of 18 children in Uzbekistan allegedly linked to a cough syrup manufactured by an Indian firm, official sources said on Thursday.
The health ministry of Uzbekistan has claimed that the 18 children had consumed cough syrup, 'Doc-1 Max', manufactured by Noida-based Marion Biotech.
Hasan Harris, legal representative of Marion Biotech, said the governments of both countries are looking into the matter and inquiring.